Suppr超能文献

相似文献

2
Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
Asian Pac J Cancer Prev. 2019 Jul 1;20(7):2087-2093. doi: 10.31557/APJCP.2019.20.7.2087.
4
The significance of salivary interleukin 6 and tumor necrosis factor alpha in patients with oral leukoplakia.
Oral Oncol. 2006 Apr;42(4):370-3. doi: 10.1016/j.oraloncology.2005.09.001. Epub 2005 Dec 1.
5
Salivary IL-6 levels in oral leukoplakia with dysplasia and its clinical relevance to tobacco habits and periodontitis.
Clin Oral Investig. 2011 Oct;15(5):705-14. doi: 10.1007/s00784-010-0435-5. Epub 2010 Jun 19.
6
Role of tissue eosinophils in oral Leukoplakia: A pilot study.
J Oral Maxillofac Pathol. 2015 Sep-Dec;19(3):286-90. doi: 10.4103/0973-029X.174647.
7
Expression of salivary levels of S100A7 in oral submucous fibrosis and oral leukoplakia.
J Oral Maxillofac Pathol. 2024 Jan-Mar;28(1):84-89. doi: 10.4103/jomfp.jomfp_113_23. Epub 2024 Apr 15.
8
Proinflammatory cytokine levels in oral lichen planus, oral leukoplakia, and oral submucous fibrosis.
J Korean Assoc Oral Maxillofac Surg. 2015 Aug;41(4):171-5. doi: 10.5125/jkaoms.2015.41.4.171. Epub 2015 Aug 21.
9
Salivary interleukin-6 in the detection of oral cancer and precancer.
Asia Pac J Clin Oncol. 2015 Sep;11(3):236-41. doi: 10.1111/ajco.12330. Epub 2015 Jan 6.
10
Assessment of lactate dehydrogenase enzyme levels in saliva and serum of oral submucous fibrosis and leukoplakia patients.
J Oral Maxillofac Pathol. 2020 Jan-Apr;24(1):183. doi: 10.4103/jomfp.JOMFP_214_19. Epub 2020 May 8.

引用本文的文献

1
Salivaomic Biomarkers-An Innovative Approach to the Diagnosis, Treatment, and Prognosis of Oral Cancer.
Biology (Basel). 2025 Jul 13;14(7):852. doi: 10.3390/biology14070852.
2
Salivary biomarkers in non-invasive oral cancer diagnostics: a comprehensive review.
J Appl Oral Sci. 2024 Sep 9;32:e20240151. doi: 10.1590/1678-7757-2024-0151. eCollection 2024.

本文引用的文献

1
Salivary biomarkers in cancer detection.
Med Oncol. 2017 Jan;34(1):7. doi: 10.1007/s12032-016-0863-4. Epub 2016 Dec 10.
2
Oral leukoplakia, the ongoing discussion on definition and terminology.
Med Oral Patol Oral Cir Bucal. 2015 Nov 1;20(6):e685-92. doi: 10.4317/medoral.21007.
3
Small heat shock proteins: Role in cellular functions and pathology.
Biochim Biophys Acta. 2015 Apr;1854(4):291-319. doi: 10.1016/j.bbapap.2014.12.019. Epub 2014 Dec 30.
5
Genetics/epigenetics of oral premalignancy: current status and future research.
Oral Dis. 2011 Apr;17 Suppl 1:7-22. doi: 10.1111/j.1601-0825.2011.01789.x.
6
Structural and functional diversities between members of the human HSPB, HSPH, HSPA, and DNAJ chaperone families.
Biochemistry. 2008 Jul 8;47(27):7001-11. doi: 10.1021/bi800639z. Epub 2008 Jun 17.
7
Nomenclature and classification of potentially malignant disorders of the oral mucosa.
J Oral Pathol Med. 2007 Nov;36(10):575-80. doi: 10.1111/j.1600-0714.2007.00582.x.
8
The significance of salivary interleukin 6 and tumor necrosis factor alpha in patients with oral leukoplakia.
Oral Oncol. 2006 Apr;42(4):370-3. doi: 10.1016/j.oraloncology.2005.09.001. Epub 2005 Dec 1.
9
Pooled estimate of world leukoplakia prevalence: a systematic review.
Oral Oncol. 2003 Dec;39(8):770-80. doi: 10.1016/s1368-8375(03)00102-7.
10
Hsp70 is present in human saliva.
Med Sci Monit. 2003 Jan;9(1):BR62-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验